Quintrio
Home

Stock overview

Purple Biotech Ltd. American Depositary Shares

PPBT

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $1.59 – $1.71
Volume 12,223
Market cap $3M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for PPBT.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for PPBT.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants

Purple Biotech closed a public offering raising $6 million upfront, with potential additional proceeds of $12 million through short-term warrant exercises. The company plans to use funds for oncology therapeutic candidate development and working capital.

GlobeNewswire Inc.

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial

Purple Biotech is advancing its novel agent NT219 into a Phase 2 study in combination with pembrolizumab or cetuximab for the treatment of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). The study aims to address the significant unmet medical need in this patient population.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Mar 2, 20261-for-10reverse split
Sep 17, 20241-for-20reverse split
Aug 21, 20201-for-10reverse split